(3S,5S,6S)-3,4,5-trihydroxy-6-(2-pentanoylbenzoyl)oxyoxane-2-carboxylic acid

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (3S,5S,6S)-3,4,5-trihydroxy-6-(2-pentanoylbenzoyl)oxyoxane-2-carboxylic acid
• 化学式: C₁₈H₂₂O₉
• 分子量: 382.4
• InChiKey: LFIMHYZGPLIRMF-BIAXPURVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  151
• 氢给体数：
  4
• 氢受体数：
  9

文献信息

• US20140271568A1
  申请人：——

  公开号：US20140271568A1

  公开（公告）日：2014-09-18
• METHOD FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL
  申请人：HAWKING BIOLOGICAL TECHNOLOGY CO., LTD

  公开号：US20160324826A1

  公开（公告）日：2016-11-10

  A method for providing an increased expression of at least one of telomerase, brain-derived neurotrophic factor (BDNF), stromal cell-derived factor-1 (SDF1), CXC chemokine receptor 4 (CXCR4), and an immune regulatory factor of a stem cell in a subject is provided. The method comprises simultaneously or separately administering to the subject an effective amount of (a) a phthalide and (b) a stem cell.